MedPath

Study to Examine the Effects of MultiStem in Ischemic Stroke

Phase 2
Completed
Conditions
Ischemic Stroke
Interventions
Biological: MultiStem
Biological: Placebo
Registration Number
NCT01436487
Lead Sponsor
Healios K.K.
Brief Summary

A study to examine the safety and potential effectiveness of the adult stem cell investigational product, MultiStem, in adults who have suffered an ischemic stroke. The hypothesis is that MultiStem will be safe and provide benefit following an ischemic stroke.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
134
Inclusion Criteria
  • Male or female subjects between 18 and 83 years of age (inclusive)
  • Clinical diagnosis of cortical cerebral ischemic stroke
  • Occurrence of a moderate to moderately severe stroke
Exclusion Criteria
  • Presence of a lacunar or a brainstem infarct
  • Reduced level of consciousness
  • Major neurological event such as stroke or clinically significant head trauma within 6 months of study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cohort 2MultiStemHigh dose MultiStem or Placebo
Cohort 1MultiStemLow dose MultiStem or Placebo
Cohort 1PlaceboLow dose MultiStem or Placebo
Cohort 2PlaceboHigh dose MultiStem or Placebo
Cohort 3MultiStemHighest, safe MultiStem dose (from Cohorts 1 and 2) or Placebo
Cohort 3PlaceboHighest, safe MultiStem dose (from Cohorts 1 and 2) or Placebo
Primary Outcome Measures
NameTimeMethod
frequency of dose limiting adverse events7 days
Stroke recovery based on global test analysis including modified Rankin Scale (mRS), NIHSS, and Barthel Index (BI)90 days
Secondary Outcome Measures
NameTimeMethod
proportion of subjects with a mRS score of less than or equal to 290 days
change in functional outcome throughout range of mRS scores90 days
changes in outcome measures (mRS, NIHSS, BI) over time365 days
proportion of subjects with an excellent functional outcome90 days

* mRS score = 0 to 1; and

* NIHSS score = 0 to 1; and

* Barthel Index score = greater than or equal to 95

frequency of adverse events365 days
change in vital signs365 days
change in safety labs365 days
frequency of secondary infections365 days

Trial Locations

Locations (32)

Summa Health System

🇺🇸

Akron, Ohio, United States

Palmetto Health Richland

🇺🇸

Columbia, South Carolina, United States

MetroHealth Medical Center

🇺🇸

Cleveland, Ohio, United States

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

University of Louisville

🇺🇸

Louisville, Kentucky, United States

Methodist Hospital Research Institute

🇺🇸

Houston, Texas, United States

University of Miami

🇺🇸

Miami, Florida, United States

Boston University

🇺🇸

Boston, Massachusetts, United States

The Pennsylvania State University

🇺🇸

Hershey, Pennsylvania, United States

University of Utah

🇺🇸

Salt Lake City, Utah, United States

Georgia Regents University

🇺🇸

Augusta, Georgia, United States

University of Kentucky Medical Center

🇺🇸

Lexington, Kentucky, United States

University of Cincinnati

🇺🇸

Cincinnati, Ohio, United States

Henry Ford Health System

🇺🇸

Detroit, Michigan, United States

University of Nebraska Medical Center

🇺🇸

Omaha, Nebraska, United States

Case Western Reserve University School of Medicine

🇺🇸

Cleveland, Ohio, United States

Oregon Health Sciences University

🇺🇸

Portland, Oregon, United States

University of Pittsburgh Medical Center Health System

🇺🇸

Pittsburgh, Pennsylvania, United States

University of Glasgow - Southern General Hospital

🇬🇧

Glasgow, United Kingdom

St. Georges Healthcare NHS Trust

🇬🇧

London, United Kingdom

Chattanooga Center for Neurologic Research

🇺🇸

Chattanooga, Tennessee, United States

University Hospital of North Staffordshire

🇬🇧

Stoke-on-Trent, United Kingdom

University of Glasgow - Western Infirmary

🇬🇧

Glasgow, United Kingdom

The Newcastle upon Tyne Hospitals, NHS Foundation Trust

🇬🇧

Newcastle upon Tyne, United Kingdom

University College London Hospitals - Thames Stroke Research Network

🇬🇧

London, United Kingdom

UCLA Medical Center

🇺🇸

Los Angeles, California, United States

Stanford University

🇺🇸

Stanford, California, United States

Florida Hospital Orlando

🇺🇸

Orlando, Florida, United States

The University of Texas Health Science Center

🇺🇸

Houston, Texas, United States

Northwestern University

🇺🇸

Chicago, Illinois, United States

University of Mississippi Medical Center

🇺🇸

Jackson, Mississippi, United States

Hospital for the University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath